When it Comes to COVID-19 Research, The US Still Has A lot to Learn
The US is thought to have the most talented scientists along with the best biomedical research infrastructure in the world. [...]
DIA DIRECT Webinar: Post-Pandemic Paradigm Shifts and New Dimensions of Value
Join Gregory Daniel, PhD, MPH, Head, US Healthcare Policy, Edwards Lifesciences; Rita Numerof, Co-Founder and President, Numerof & Associates; and [...]
ICER to Assess CAR-T Cell Therapies for Multiple Myeloma
The Institute for Clinical and Economic Review (ICER) announced its intention to evaluate the comparative clinical effectiveness and value of [...]
Draft Scoping Document on Lupus Nephritis Posted by ICER
In a draft scoping document, the Institute for Clinical and Economic Review (ICER) outlined plans to review the comparative clinical [...]
Amazon Launches Silent Healthcare Coup
In addition to its major market positions in logistics and cloud storage, Amazon is making quiet forays into healthcare. Although [...]
Gaps in Biosimilar Assessment Reports Pique Investigator Interest
According to a recent evaluation of health technology assessments (HTAs) for biosimilars, researchers found the majority of HTAs lack systematic [...]
Journal of Managed Care and Specialty Pharmacy (JMCP) Electronic Table of Contents Now Available for September 2020
Features in this issue include: Medication Therapy Management: 10 Years of Experience in a Large Integrated Health Care System Editor’s [...]
ICER finds BioMarin’s Hemophilia Gene Therapy Could Have Warranted a Record Price Tag
Hemophilia is a very expensive disease to treat. Therapies that provide replacement clotting protein are not entirely effective but still [...]
Data Exchange for Drug Rebate Processing and Contract Management Enhanced by HealthVerity’s Latest Acquisition
An industry leader in privacy-protected data exchange, HealthVerity, acquired the industry’s leading innovator in cloud-based drug rebate processing and contract [...]
The Influence of HEOR Data on Payer Formulary Coverage
A recent study presented by ISPOR demonstrated how HEOR data positively influenced changes to US payer formulary coverage. Investigators surveyed [...]
Allina and Blue Cross Blue Shield of Minnesota Enter Sweeping Value-based Pact
Improving patient care and cutting costs was the primary motivation for the new, multiyear pact agreed to by Allina Health [...]
Up Your Professional Game by Joining an Academy of Managed Care Pharmacy Committee
Help move the field of managed care forward by joining an AMCP committee and sharing your experience and expertise. Joining [...]
How Can Employers Make Pricey Gene Therapies and Specialty Drugs Less Costly?
A recent survey found that several large American firms plan to employ a variety of strategies to mitigate expenses and [...]
COVID-19 Exposes Limitations of Traditional Quality Measures
COVID-19 has highlighted many weaknesses in the healthcare system including slow implementation of clinical guidelines and development of quality measures [...]
Webinar: How Can Whole Genome Sequencing Optimize Care?
Rare diseases put a tremendous burden on our healthcare system. With over 80% of rare diseases thought to be genetic [...]
Which Digital enhancements Are Worth the Investment? Find Out in the latest InformED Podcast.
Join Travis Hicks for a discussion on how different publication enhancement options can improve understanding and increase availability of data. [...]
Join Healthcare Information and Management Systems Society (HIMSS) for their Digital European Health Conference
The HIMSS & Health 2.0 European Digital Event from September 7-11, 2020 will combine HIMSS's knowledge, expertise and thought leadership [...]
Market Expertz Releases New Report: Global Value-Based Reimbursement Software Market Report.
New report published by Market Expertz provides detailed overview of vital market components that aid in assessing current and future [...]
Virtual ISPOR-FDA Summit 2020: Using Patient-Preference Information in Medical Device Regulatory Decisions: Benefit-Risk and Beyond
Regulatory decision making for medical devices is increasingly drawing upon Patient-preference information (PPI). Join 18 industry experts on September 29, [...]
HEOR News Magazine ‘Value & Outcomes Spotlight’ Now Available Online
Value & Outcomes Spotlight is a bimonthly HEOR news magazine that provides feature articles on timely HEOR topics, methodological issues, [...]
The United States Postal Service: An Often Overlooked but Vital Part of Our Health Care System
Many depend on the postal service for their medications, so any disruptions to the USPS will create substantial barriers to [...]
New E-book Available from the World Healthcare Congress: How Healthy Are Your Market Access Programs? A guide to performing check-ups on pharmaceutical distribution and patient access programs.
In the World Healthcare Congress’ new E-book, find out why most programs experience service disruptions, face unforeseen challenges, and receive [...]
Innovation and Value Initiative’s (IVI) Jennifer Bright on Value Assessment and Transparency
Jennifer Bright is Executive Director of the Innovation and Value Initiative (IVI), a non-profit organization whose mission is to to [...]
Drugmakers Hope to Trump International Pricing Plan with Counterproposal
Drugmakers hope to stall Trump’s ‘preferred nations’ directive by making a counteroffer to the White House. The president’s directive aims [...]
Upcoming Academy of Managed Care Pharmacy (AMCP) Webinar: Helping Patients Anticipate and Manage Drug Costs
Join Joe Honcz, RPh, MBA, Principal C4i and Kollet Koulianos, MBA, Senior Director Payer Relations, National Hemophilia Foundation (NHF) on [...]